MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Superior cerebellar peduncles atrophy of PSP on PADRE imaging; comparison with idiopathic PD

    S. Kakeda, M. Miyata, T. Yoneda, S. Ide, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: The purpose of our study was to determine whether atrophy of Superior cerebellar peduncles (SCP) on phase-weighted magnetic resonance imaging technique (PADRE) was useful…
  • 2018 International Congress

    Neuromodulatory properties of flavonoids from Persea americana Peel: Role in CNS redox homeostasis and neurobehavioral markers

    S. Grace SR, PR, J. Chauhan, G. Chandran (Mys, India)

    Objective: Isolating flavonoids from Peel of Persea americana fruits & testing their effects on CNS redox homeostasis culminating in neurobehavioural amelioration among rats. Background: Cellular…
  • 2018 International Congress

    Bereitschaftspotential in a Patient with Functional Propriospinal Myoclonus

    C.H. Tsai, M.K. Lu, Y.F. Chen, Y.Y. Chang, J.C. Chen (Taichung, Taiwan)

    Objective: To illustrate the presence and characteristics of functional propriospinal myoclonus with Bereitschaftspotential (BP). Background: The etiology of propriospinal myoclonus is mostly uncertain and functional…
  • 2018 International Congress

    Final Safety Results of EASE LID 2 Study: Long Term Open-Label Study of ADS-5102 for Dyskinesia in Parkinson’s disease (PD) patients

    S. Isaacson, R. Pahwa, C. Tanner, R. Hauser, W. Oertel, R. Johnson, L. Felt, M.J. Stempien, R. Patni (Boca Raton, FL, USA)

    Objective: The primary objective of this study was the safety and tolerability of ADS-5102 in PD patients with dyskinesia. Secondary efficacy outcome measures included MDS-UPDRS,…
  • 2018 International Congress

    Dyskinesia management in COMT-naïve patients starting adjunctive therapy with opicapone: The BIPARK-I double-blind experience

    J. Pagonabarraga, E. Tolosa, J. Ferreira, A. Lees, E. Arbe, J. Rocha, P. Soares-da-Silva (Barcelona, Spain)

    Objective: To elucidate which levodopa-treated COMT-naïve Parkinson’s Disease (PD) patients were at higher risk for developing dyskinesia when starting opicapone (OPC) 50mg or entacapone (ENT).…
  • 2018 International Congress

    Exploring the utility of the ChulaPD intelligent Parkinson’s disease car to determine naturalistic driving ability in Parkinson’s disease patients: A pilot study of 10 patients

    O. Jitkritsadakul, S. Krootjohn, P. Yanthitirat, C. Anan, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To examine the naturalistic driving performance in PD patients compared to controls and to determine if the PD patients showed diminished abilities. Background: Competence…
  • 2018 International Congress

    The Interface of advanced therapies as Parkinson’s disease progresses – case reports

    C. Liang, S. Williams, L. Jones, C. Sue, P. Silberstein (St Leonards, Australia)

    Objective: To explore the practical benefits and challenges of adding duodenal levodopa-carbidopa intestinal gel infusion (LCIG) to subthalamic nucleus deep brain stimulation (STN DBS) in…
  • 2018 International Congress

    Neuromodulatory role of subthalamic nucleus deep brain stimulation in Parkinson’s disease patients

    S. Szlufik, A. Przybyszewski, K. Duszynska-Was, I. Laskowska-Levy, J. Dutkiewicz, A. Drzewinska, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of study was to evaluate the impact of subthalamic nucleus deep brain stimulation (STN-DBS) on the motor disabilities and cognitive alterations in…
  • 2018 International Congress

    Directional Lead Impedances and Their Possible Effects on Deep Brain Stimulation

    L. Juarez Paz, A. Dalal Kirsch, F. Steigerwald, C. Matthies, S. Meoni, V. Fraix, T. Ten Brinke, R. de Bie, K. Wynants, D. Blum, N. Van Dyck, PR. Schuurman, E. Moro, S. Chabardes, J. Volkmann (Valencia, CA, USA)

    Objective: The objective was to characterize the possible effects that directional leads impedances have on Deep Brain Stimulation (DBS) therapy. Background: DBS of the subthalamic…
  • 2018 International Congress

    Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation (CLOVER-DBS)

    F. Sasaki, G. Oyama, S. Sekimoto, R. Nakamura, T. Jo, H. Iwamuro, A. Umemura, Y. Shimo, N. Hattori (Tokyo, Japan)

    Objective: To assess the feasibility and efficacy of a novel closed-loop programming algorithm (CLPA) for deep brain stimulation (DBS) based on objective feedback using a…
  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 177
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley